Insiders · Profile

Yocum Richard C

VP Clinical Development at HALOZYME THERAPEUTICS. Filing since 22 Mar 2007. CIK 0001323495

Company
Date
Role
Action
Shares
Amount
Of holding
22 Mar 2007
VP Clinical Development
Sold, plan not stated
29,858
$253.46K
31.2%
1 decision on file.